Bringing the Sleeping Beauty transposon system to the clinic

Cell & Gene Therapy Insights 2023; 9(9), 1183–1189

DOI: 10.18609/cgti.2023.156

Published: 18 October 2023
Zoltán Ivics

The range of technology options for nucleic acid delivery and genome engineering continues to expand, with a number of promising platforms now entering the clinic. David McCall, Senior Editor, Cell & Gene Therapy Insights, speaks with Zoltán Ivics, Head of Research Centre, Division of Hematology, Gene and Cell Therapy at the Paul-Ehrlich-Institut, about recent progress and next steps for one such example—the Sleeping Beauty transposon system.